HEALTH● LOWAug 6 · Aug 6, 2026, 5:35 PM
Lexicon anticipates Zynquista NDA resubmission in Q4 2026 as SONATA-HCM top line data expected in Q1 2027
Seeking Alpha Tech
Lexicon expects to resubmit the New Drug Application (NDA) for Zynquista in the fourth quarter of 2026. Additionally, top-line data from the SONATA-HCM trial is anticipated in the first quarter of 2027.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH49m agoPfizer sees strong response for pediatric pneumonia vaccine in mid-stage trialSeeking Alpha TechHEALTH1h agoManila Doctors Hospital , Benilde partner for accessible servicesphilstar.com · PhilippinesHEALTH1h agoNMC withdraws 2023 rules on medical education standards, raising accountability concernsThe HinduHEALTH1h agoAmerica’s next great addiction crisisThe Hill